Literature DB >> 2981261

Immunoradiometric assay to measure the in vitro penetration of sporozoites of malaria parasites into hepatoma cells.

F Zavala, M R Hollingdale, A L Schwartz, R S Nussenzweig, V Nussenzweig.   

Abstract

We describe here an immunoradiometric assay to quantitate the in vitro invasion of hepatoma cells by sporozoites. The assay measures levels of circumsporozoite (CS) antigen that remain associated with the hepatoma cells after their incubation with the parasites. Several observations show that these measurements reflect internalized rather than extracellular antigen. For example, when incubations were performed with nonviable parasites (sonicated or heated), or in the presence of metabolic inhibitors, such as sodium azide and deoxyglucose, the amounts of CS antigen found in hepatoma cell extracts were greatly diminished. Moreover, Western blotting experiments revealed a striking difference in the pattern of CS proteins of infected cell extracts as compared with those of free parasites. The assay was used to measure the amounts of intracellular CS antigen for several days after infection of the hepatoma cells. The results confirmed previous microscopic observations, made by using immunofluorescence techniques, showing that the CS antigen in the host's liver cells diminishes progressively while the parasite develops into the exoerythrocytic stage. The immunoradiometric assay should facilitate the evaluation of the effects of drugs on sporozoites and also on studies aimed at the identification of a sporozoite receptor on the hepatocyte.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981261

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Survival and antigenic profile of irradiated malarial sporozoites in infected liver cells.

Authors:  A Suhrbier; L A Winger; E Castellano; R E Sinden
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

2.  Immunization of mice with live-attenuated late liver stage-arresting Plasmodium yoelii parasites generates protective antibody responses to preerythrocytic stages of malaria.

Authors:  Gladys J Keitany; Brandon Sack; Hannah Smithers; Lin Chen; Ihn K Jang; Leslie Sebastian; Megha Gupta; D Noah Sather; Marissa Vignali; Ashley M Vaughan; Stefan H I Kappe; Ruobing Wang
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

Review 3.  Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design.

Authors:  Javier E Garcia; Alvaro Puentes; Manuel E Patarroyo
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

4.  Plasmodium berghei sporozoite invasion is blocked in vitro by sporozoite-immobilizing antibodies.

Authors:  M J Stewart; R J Nawrot; S Schulman; J P Vanderberg
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

5.  A liver-stage specific antigen of P. berghei identified by a monoclonal antibody.

Authors:  L Winger; A Suhrbier; C A O'Dowd; K J Hodivala; R E Sinden
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

6.  An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens.

Authors:  Ana Rodríguez-Galán; Ahmed M Salman; Georgina Bowyer; Katharine A Collins; Rhea J Longley; Florian Brod; Marta Ulaszewska; Katie J Ewer; Chris J Janse; Shahid M Khan; Julius C Hafalla; Adrian V S Hill; Alexandra J Spencer
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

7.  A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite.

Authors:  Neville K Kisalu; Azza H Idris; Connor Weidle; Yevel Flores-Garcia; Barbara J Flynn; Brandon K Sack; Sean Murphy; Arne Schön; Ernesto Freire; Joseph R Francica; Alex B Miller; Jason Gregory; Sandra March; Hua-Xin Liao; Barton F Haynes; Kevin Wiehe; Ashley M Trama; Kevin O Saunders; Morgan A Gladden; Anthony Monroe; Mattia Bonsignori; Masaru Kanekiyo; Adam K Wheatley; Adrian B McDermott; S Katie Farney; Gwo-Yu Chuang; Baoshan Zhang; Natasha Kc; Sumana Chakravarty; Peter D Kwong; Photini Sinnis; Sangeeta N Bhatia; Stefan H I Kappe; B Kim Lee Sim; Stephen L Hoffman; Fidel Zavala; Marie Pancera; Robert A Seder
Journal:  Nat Med       Date:  2018-03-19       Impact factor: 53.440

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.